möglich sobald bei der ZB eingereicht worden ist.
Cross-talk of NADPH oxidases and inflammation in obesity.
Antioxidants 12:17 (2023)
Obesity is a major risk factor for cardiovascular and metabolic diseases. Multiple experimental and clinical studies have shown increased oxidative stress and inflammation linked to obesity. NADPH oxidases are major sources of reactive oxygen species in the cardiovascular system and in metabolically active cells and organs. An impaired balance due to the increased formation of reactive oxygen species and a reduced antioxidative capacity contributes to the pathophysiology of cardiovascular and metabolic diseases and is linked to inflammation as a major pathomechanism in cardiometabolic diseases. Non-alcoholic fatty liver disease is particularly characterized by increased oxidative stress and inflammation. In recent years, COVID-19 infections have also increased oxidative stress and inflammation in infected cells and tissues. Increasing evidence supports the idea of an increased risk for severe clinical complications of cardiometabolic diseases after COVID-19. In this review, we discuss the role of oxidative stress and inflammation in experimental models and clinical studies of obesity, cardiovascular diseases, COVID-19 infections and potential therapeutic strategies.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Schlagwörter
Covid-19 ; Antioxidants ; Cardiometabolic Diseases ; Inflammation ; Non-alcoholic Fatty Liver Disease ; Obesity ; Oxidative Stress ; Reactive Oxygen Species; Adenine-dinucleotide Phosphate; Vascular Oxidative Stress; Cardiovascular-disease; Endothelial Receptor; Insulin-resistance; Nad(p)h Oxidase; Up-regulation; Covid-19; Nox4; Deficiency
ISSN (print) / ISBN
2076-3921
e-ISSN
2076-3921
Zeitschrift
Antioxidants
Quellenangaben
Band: 12,
Heft: 8,
Artikelnummer: 17
Verlag
MDPI
Verlagsort
St Alban-anlage 66, Ch-4052 Basel, Switzerland
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute for Pancreatic Beta Cell Research (IPI)
Förderungen
German Federal and State Governments
German Centre for Cardiovascular Research (DZHK)
Deutsche Forschungsgemeinschaft (DFG)
German Centre for Cardiovascular Research (DZHK)
Deutsche Forschungsgemeinschaft (DFG)